Novo Nordisk A/S/ DK0062498333 /
14.06.2024 9:35:42 | Изменение +7.95 | Объем сделки | Бид10:06:12 | Предложение10:06:12 | Рыночная капитализация | Дивидендная доходность | Коэффициент Цена/Доход |
---|---|---|---|---|---|---|---|
992.00DKK | +0.81% | 140 Оборот: 138,692.95 |
979.10Величина цены спроса: 234 | 983.20Величина цены предложения: 60 | 3386.91 млрдDKK | 0.95% | 52.81 |
GlobeNewswire
9:11
Early Signals by WOO X: BTC Faces Downward Trend While TON Ecosystem Reaches New Highs with Surging ...
GlobeNewswire
9:01
Editas Medicine Reports New Safety and Efficacy Data from the RUBY Trial of Reni-cel in 18 Patients ...
GlobeNewswire
9:00
Beam Therapeutics Reports Data Highlighting Optimized Manufacturing Process for BEAM-101, an Investi...
GlobeNewswire
9:00
Editas Medicine Announces New Safety and Efficacy Data from the EdiTHAL Trial of Reni-cel in 7 Patie...
GlobeNewswire
9:00
Samsung Bioepis Presents Post-hoc Analysis of Phase 3 Study for EPYSQLI™ (SB12; Eculizumab Biosimila...
GlobeNewswire
8:00
Cabaletta Bio Reports Positive Initial Clinical Data from Phase 1/2 RESET-Myositis™ and RESET-SLE™ T...
GlobeNewswire
7:00
Molecular Partners Presents Positive Preclinical Data for First Switch-DARPin Candidate MP0621 at EH...
- Первая страница
- Назад
- 1
- 2
- 3
- 4
- Следующий
- Последняя страница